Search research articles
Contact Us
Filters
Showing results (161-170 of 202) with videos related to
Page
of 21
Sort By:
Vaccine
|
February 21, 2022
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use
Erin Sparrow, Ifedayo Adetifa, Nathorn Chaiyakunapruk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 24, 2008
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda
Beth Temple, Irene Ayakaka, Sam Ogwang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2012
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis
Kevin P Fennelly, Edward C Jones-López, Irene Ayakaka, et al.
The Lancet. Infectious Diseases
|
September 10, 2018
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith, Joachim Hombach, Neil Ferguson, et al.
Plos Medicine
|
March 23, 2011
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study
Edward C Jones-López, Irene Ayakaka, Jonathan Levin, et al.
Vaccine
|
February 25, 2022
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop
Eloise Williams, Kathrine Craig, Christopher Chiu, et al.
Plos One
|
March 11, 2014
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study
Bruce J Kirenga, Jonathan Levin, Irene Ayakaka, et al.
Nature Communications
|
January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
Daniel Aird, Teng Teng, Chia-Ling Huang, et al.
Blood
|
June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma
Michael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
The New England Journal of Medicine
|
September 27, 2024
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial
Katherine E Gallagher, Ruth Lucinde, Christian Bottomley, et al.
Page
of 21
Search research articles
Search
Showing results (161-170 of 202) with videos related to
Sort By:
Page
of 21
Vaccine
|
February 21, 2022
WHO preferred product characteristics for monoclonal antibodies for passive immunization against respiratory syncytial virus (RSV) disease in infants - Key considerations for global use
Erin Sparrow, Ifedayo Adetifa, Nathorn Chaiyakunapruk, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
September 24, 2008
Rate and amplification of drug resistance among previously-treated patients with tuberculosis in Kampala, Uganda
Beth Temple, Irene Ayakaka, Sam Ogwang, et al.
American Journal of Respiratory and Critical Care Medicine
|
July 17, 2012
Variability of infectious aerosols produced during coughing by patients with pulmonary tuberculosis
Kevin P Fennelly, Edward C Jones-López, Irene Ayakaka, et al.
The Lancet. Infectious Diseases
|
September 10, 2018
Deliberations of the Strategic Advisory Group of Experts on Immunization on the use of CYD-TDV dengue vaccine
Annelies Wilder-Smith, Joachim Hombach, Neil Ferguson, et al.
Plos Medicine
|
March 23, 2011
Effectiveness of the standard WHO recommended retreatment regimen (category II) for tuberculosis in Kampala, Uganda: a prospective cohort study
Edward C Jones-López, Irene Ayakaka, Jonathan Levin, et al.
Vaccine
|
February 25, 2022
Ethics review of COVID-19 human challenge studies: A joint HRA/WHO workshop
Eloise Williams, Kathrine Craig, Christopher Chiu, et al.
Plos One
|
March 11, 2014
Treatment outcomes of new tuberculosis patients hospitalized in Kampala, Uganda: a prospective cohort study
Bruce J Kirenga, Jonathan Levin, Irene Ayakaka, et al.
Nature Communications
|
January 13, 2019
Sensitivity to splicing modulation of BCL2 family genes defines cancer therapeutic strategies for splicing modulators
Daniel Aird, Teng Teng, Chia-Ling Huang, et al.
Blood
|
June 8, 2010
MLN4924, a NEDD8-activating enzyme inhibitor, is active in diffuse large B-cell lymphoma models: rationale for treatment of NF-{kappa}B-dependent lymphoma
Michael A Milhollen, Tary Traore, Jennifer Adams-Duffy, et al.
The New England Journal of Medicine
|
September 27, 2024
Fractional Doses of Pneumococcal Conjugate Vaccine - A Noninferiority Trial
Katherine E Gallagher, Ruth Lucinde, Christian Bottomley, et al.
Page
of 21